Pharmaceutical Companies
Iroko Pharmaceuticals Makes Strategic Additions to Executive Team with Appointment of Clarence L. Young, M.D. as Chief Medical Officer and Moji James as General Counsel
Published in Pharma Business Week, April 30th, 2012
2012 APR 30 -- Iroko Pharmaceuticals, LLC announces two key additions to its management team, Clarence L. Young, M.D., as Chief Medical Officer and Moji James as General Counsel and Vice President. Dr. Young will lead Iroko's extensive clinical programs for the company's investigational nonsteroidal anti-inflammatory drugs (NSAID) and Ms. James will oversee Iroko's legal and compliance activities. Both Dr. Young and Ms. James will report to John Vavricka, President and Chief Executive Officer (CEO) of Iroko Pharmaceuticals.
"Over the past five years, Iroko has been able to attract a top-notch management team of proven industry veterans with a clear vision...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Business Week
Source: Pharma Business Week (2012-04-30)
More Articles from Pharma Business Week
- Adventrx Pharmaceuticals, Inc.
ADVENTRX Pharmaceuticals to Sponsor & Present at the Martin Center's 2012 Sickle Cell Disease Conference - Research and Markets
Colombia Pharmaceuticals and Healthcare Report Q2 2012 - Prix Galien Usa
The Galien Foundation Announces Prix Galien USA Awards Committee, Chaired by Dr. P. Roy Vagelos - Biotechnology
Alnylam to Webcast Presentation at Future Leaders in the Biotech Industry Conference - Psoriasis
Despite a Slight Increase in the Use of Biologic Agents to Treat Psoriasis in the Past Year, Dermatologists in the EU Are Not Expected to Drastically Change Their Future Prescribing Habits - Hepatitis C Virus
Gilead Announces Sustained Virologic Response Data for 12-Week Regimen of GS-7977 Plus Pegylated Interferon and Ribavirin in Genotype 1 Hepatitis C Patients - More from this issue of Pharma Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
